Yazen

Yazen is a Lund-based digital healthcare company offering a holistic obesity treatment platform combining GLP-1 medications (such as Wegovy and Mounjaro) with personalized lifestyle coaching through a mobile app. Founded in 2021, Yazen has grown rapidly on the back of the Ozempic wave, amassing 20,000+ paying members in Sweden before expanding across Europe. The company raised €19.5 million in a Series A round in November 2024 led by Evli Growth Partners and Helsana HealthInvest, bringing total funding to ~€22.6 million.